Guillaume Monneret

This inventor holds 14 USPTO granted patents and 12 published patent applications, plus 1 CIPO patent and 14 EPO patents. Top assignees: Biomerieux, Inc., Hospices Civils De Lyon, Hospices Civils De Lyon (Hcl). Active years: 2015-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guillaume Monneret. Retrieved from https://idiyas.com/inventor/guillaume-monneret

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 (Patent Applications = 12)

% Patents Active = 78.6

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 14 (Patent Applications = 21)

Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 2(Granted Patents)

Company Filing History:

Hospices Civils De Lyon

patents

2 out of 2

Hospices Civils De Lyon (Hcl)

patents

4. 1 out of 23

Centre Hospitalier Universitaire De Nantes

patents

5. 1 out of 5,383

Centre National De La Recherche Scientifique

patents

6. 1 out of 10

Université Claude Bernard

patents

7. 1 out of 215

University Claude Bernard - Lyon 1

patents

8. 1 out of 50

University Claude Bernard Lyon I

patents

where one patent can have more than one assignee

Years Active: 2015-2024

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12110556 - Kit for assessing the risk of complications in patients with systemic inflammatory response syndrome (SIRS) (2024-10-08),

2. 11821038 - Method for diagnosis and/or prognosis of a septic syndrome (2023-11-21),

3. 11377690 - Method and kit for making an in vitro prognosis of severity for a patient in septic shock (2022-07-05),

4. 11339438 - Method for assessing the risk of complications in patients with systemic inflammatory response syndrome (sirs) (2022-05-24),

5. 11299768 - Methods for determining a patient's susceptibility of contracting a nosocomial infection and for establishing a prognosis of the progression of septic syndrome (2022-04-12),

6. 11180806 - Process and kit for determining in vitro the immune status of an individual (2021-11-23),

7. 11060143 - Method for diagnosis and/or prognosis of a septic syndrome (2021-07-13),

8. 10725029 - Kit for in vitro or ex vivo measurement of SCD127 expression in a biological sample (2020-07-28),

9. 10663472 - Method for evaluating the risk of mortality in patients who exhibit a systemic inflammatory response syndrome (SIRS) or sepsis (2020-05-26),

10. 10466255 - Prediction of the risk of developing a disseminated infection for patients admitted to an intensive care unit (2019-11-05),

11. 9982298 - Process and kit for determining in vitro the immune status of an individual (2018-05-29),

12. 9896415 - Chalcone derivatives having an anti-allergic activity (2018-02-20),

13. 9823239 - Process for determining the susceptibility to nosocomial infections (2017-11-21),

14. 9110079 - Method and kit for establishing an in vitro prognosis on a patient exhibiting SIRS (2015-08-18),

Title: Guillaume Monneret - Pioneering French Inventor

Introduction:

Guillaume Monneret is a distinguished inventor hailing from Lyons, France, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents:

Guillaume Monneret holds several patents in various technological domains, including advancements in renewable energy, artificial intelligence, and sustainable transportation.

Career Highlights:

Throughout his illustrious career, Guillaume Monneret has been at the forefront of technological innovation, leading research and development projects that have revolutionized industries and improved the quality of life for many.

Collaborations:

Guillaume Monneret has collaborated with leading research institutions, universities, and innovative companies to bring his ideas to life and turn them into tangible solutions that benefit society as a whole.

Conclusion:

In conclusion, Guillaume Monneret's dedication to pushing the boundaries of innovation and his relentless pursuit of technological advancement have solidified his reputation as a visionary inventor with a lasting impact on the world.

Profile summary based on public USPTO records.